Plain-language summary
Intrauterine adhesion is a fibrotic disease of the uterus in which scar tissue forms inside the cavity, often after surgery, and it is a leading cause of female infertility. Treatment struggles because the fibrosis tends to return. Mesenchymal stem cell extracellular vesicles have shown promise in small animals, but translation has been slow, partly because free vesicles do not stay in place and large-animal evidence has been missing. In this study the researchers packaged vesicles from pigs' own adipose-derived stem cells inside a temperature-sensitive chitosan hydrogel and tested the combination in a pig model of intrauterine adhesion. Treated animals showed less fibrosis, better-preserved tissue architecture and improved vascularization. Single-cell sequencing showed that the vesicles reshaped fibroblast populations, damping down two pro-fibrotic clusters. MiRNA profiling then pinpointed miR-423-5p as a functional cargo that directly binds the SMAD3 transcript, restraining TGF-beta/Smad signaling, the core pathway driving organ fibrosis. This is the first demonstration of the approach in pigs.
Key findings
- Extracellular vesicles from adipose-derived mesenchymal stem cells were delivered in a thermosensitive chitosan hydrogel in a pig model of intrauterine adhesion, a fibrotic cause of infertility.
- The treated animals developed less fibrosis, better-preserved endometrial architecture and stronger vascularization than controls.
- Single-cell sequencing showed the vesicles selectively suppressed two pro-fibrotic fibroblast subpopulations rather than acting indiscriminately.
- MiR-423-5p carried by the vesicles directly targets the SMAD3 transcript, restraining the TGF-beta/Smad pathway that drives organ fibrosis.
Why this matters for lung repair
Although this study concerns endometrial rather than lung tissue, its central mechanism — vesicle miRNA acting on the SMAD3 node of TGF-beta signaling — belongs to the same fibrotic pathway implicated in pulmonary fibrosis, and the hydrogel carrier addresses the vesicle-retention problem that also limits inhaled and topical delivery.
Original abstract
Intrauterine adhesion (IUA), a fibrotic cause of female infertility, lacks effective therapies due to high recurrence following surgical intervention. Extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) show promise in small-animal models, yet clinical translation is hindered by poor retention and the absence of large-animal validation. To address this, we developed a thermosensitive chitosan hydrogel (GelCT) as an EV carrier for autologous adipose MSC-EV delivery in a porcine IUA model. EVs-GelCT significantly attenuated fibrosis, restored endometrial architecture, and enhanced vascularization. Single-cell transcriptomics revealed that EVs remodel fibroblast subpopulations, specifically suppressing pro-fibrotic F2 (ECM-reparative) and F3 (inflammation-associated) clusters. Integrated miRNA profiling identified miR-423-5p as a functional EV cargo that directly targets SMAD3 3'UTR, thereby inhibiting TGF-β/Smad signaling. This first-in-porcine demonstration establishes the miR-423-5p/SMAD3 axis as a therapeutically actionable mechanism for IUA, advancing EV-based strategies from proof of concept to clinical translation.
Frequently asked questions
What did this study find?
Intrauterine adhesion is a fibrotic disease of the uterus in which scar tissue forms inside the cavity, often after surgery, and it is a leading cause of female infertility. Treatment struggles because the fibrosis tends to return. Mesenchymal stem cell extracellular vesicles have shown promise in small animals, but translation has been slow, partly because free vesicles do not stay in place and large-animal evidence has been missing. In this study the researchers packaged vesicles from pigs' own adipose-derived stem cells inside a temperature-sensitive chitosan hydrogel and tested the combination in a pig model of intrauterine adhesion. Treated animals showed less fibrosis, better-preserved tissue architecture and improved vascularization. Single-cell sequencing showed that the vesicles reshaped fibroblast populations, damping down two pro-fibrotic clusters. MiRNA profiling then pinpointed miR-423-5p as a functional cargo that directly binds the SMAD3 transcript, restraining TGF-beta/Smad signaling, the core pathway driving organ fibrosis. This is the first demonstration of the approach in pigs.
Was this tested in humans or in the laboratory?
This is preclinical work — the findings come from laboratory models, not from human participants.
Where can I read the original paper?
The full text lives with the publisher: https://doi.org/10.1016/j.mtbio.2026.103574
Does this study prove that JuvGuard works?
No. This is an independent, peer-reviewed study on extracellular vesicles. JuvGuard references the published literature for education only. A single paper cannot establish that any product works, and nothing here is medical advice.
How to cite this paper
Xu Xiao, Wang Xiaomin, Tian Quan, Lv Junlin, Pan Nailong, Shang Zhen et al.. Adipose-derived extracellular vesicles miR-423-5p targets SMAD3 to reverse endometrial fibrosis in a porcine model of intrauterine adhesion: insights from single-cell sequencing.. Materials today. Bio. 2026, 2026-09-14. DOI: 10.1016/j.mtbio.2026.103574
Source & verification
- Journal: Materials today. Bio
- Published: 14 September 2026
- DOI: 10.1016/j.mtbio.2026.103574
- PubMed ID: 42733683
- Indexed via: pubmed
- MeSH terms: —